[HTML][HTML] Acute stroke management pathway during Coronavirus-19 pandemic
C Baracchini, A Pieroni, F Viaro, V Cianci… - Neurological …, 2020 - Springer
Since the outbreak of the COVID-19 epidemic which in our region, Veneto (Italy), dates back
to February, we were confronted with several challenges, but with a constant aim of keeping …
to February, we were confronted with several challenges, but with a constant aim of keeping …
Antibody response to first and second dose of BNT162b2 in a cohort of characterized healthcare workers
Background Vaccine-induced population immunity is a key global strategy to control coronavirus
disease 2019 (COVID-19). The rapid implementation and availability of several COVID-…
disease 2019 (COVID-19). The rapid implementation and availability of several COVID-…
[HTML][HTML] Neutralizing antibody titers six months after Comirnaty vaccination: kinetics and comparison with SARS-CoV-2 immunoassays
…, A Bortolami, A Cattelan, V Cianci… - Clinical Chemistry and …, 2022 - degruyter.com
Objectives mRNA vaccines, including Comirnaty (BNT162b2 mRNA, BioNTech-Pfizer), elicit
high IgG and neutralizing antibody (NAb) responses after the second dose, but the …
high IgG and neutralizing antibody (NAb) responses after the second dose, but the …
[HTML][HTML] Impact of antigen test target failure and testing strategies on the transmission of SARS-CoV-2 variants
…, E Franchin, L Manuto, F Bianca, V Cianci… - Nature …, 2022 - nature.com
Population testing remains central to COVID-19 control and surveillance, with countries
increasingly using antigen tests rather than molecular tests. Here we describe a SARS-CoV-2 …
increasingly using antigen tests rather than molecular tests. Here we describe a SARS-CoV-2 …
SARS-CoV-2 neutralizing antibodies after one or two doses of Comirnaty (BNT162b2, BioNTech/Pfizer): Kinetics and comparison with chemiluminescent assays
…, M Pagliari, A Bortolami, A Cattelan, V Cianci… - Clinica Chimica …, 2021 - Elsevier
Background Studies evaluating neutralizing antibody (NAb) after BNT162b2 vaccine are
scarce. We therefore compared NAb using the plaque reduction neutralization test (PRNT) in …
scarce. We therefore compared NAb using the plaque reduction neutralization test (PRNT) in …
[HTML][HTML] A cohort analysis of SARS-CoV-2 anti-spike protein receptor binding domain (RBD) IgG levels and neutralizing antibodies in fully vaccinated healthcare …
…, L Dall'Olmo, L Galla, A Cattelan, V Cianci… - Clinical Chemistry and …, 2022 - degruyter.com
Objectives The waning of humoral immunity after COVID-19 vaccine booster (third dose)
has not yet been fully evaluated. This study updates data on anti-SARS-CoV-2 spike protein …
has not yet been fully evaluated. This study updates data on anti-SARS-CoV-2 spike protein …
Emergence of N antigen SARS-CoV-2 genetic variants escaping detection of antigenic tests
…, F Onelia, E Franchin, L Manuto, F Bianca, V Cianci… - MedRxiv, 2021 - medrxiv.org
SARS-CoV-2 genetic variants are emerging as a major threat to vaccination efforts worldwide
as they may increase virus transmission rate and/or confer the ability to escape vaccine …
as they may increase virus transmission rate and/or confer the ability to escape vaccine …
Using high sensitivity cardiac troponin values in patients with SARS-CoV-2 infection (COVID-19): The Padova experience
…, D Donato, M Plebani, R Vettor, S Iliceto, V Cianci… - Clinical …, 2021 - Elsevier
Background The spectrum of Coronavirus Disease 2019 (COVID-19) is broad and thus early
appropriate risk stratification can be helpful. Our objectives were to define the frequency of …
appropriate risk stratification can be helpful. Our objectives were to define the frequency of …
Differentiation of cardiac and noncardiac dyspnea using bioelectrical impedance vector analysis (BIVA)
A Piccoli, M Codognotto, V Cianci, G Vettore… - Journal of cardiac …, 2012 - Elsevier
BACKGROUND: There is no gold standard for the differential diagnosis of acute dyspnea
despite the usefulness of N-terminal pro–B-type natriuretic peptide (NT-proBNP) and lung …
despite the usefulness of N-terminal pro–B-type natriuretic peptide (NT-proBNP) and lung …
Direct or early Discharge of Acute Bacterial Skin and Skin Structure Infection patients from the Emergency Department/Unit: place in therapy of dalbavancin
A Oliva, S Carbonara, V Cianci, M Crapis… - Expert Review of Anti …, 2023 - Taylor & Francis
Introduction Acute Bacterial Skin and Skin Structure Infections (ABSSSIs) are a common
reason of Emergency Department (ED) access and account for a considerable number of …
reason of Emergency Department (ED) access and account for a considerable number of …
